MeSH tree: B04.820.578.500.540.150
New research has uncovered a hidden pathway that allows COVID-19 to infect the immune system and trigger damaging inflammation in the lungs. The study by La Trobe University and WEHI researchers found SARS-CoV-2, the virus ...
Jul 9, 2026
0
12
In the first two years of the COVID-19 pandemic in Quebec, through seven waves of outbreaks, SARS-CoV-2 tended to infect young adults first before the rest of the population, a new study shows. That makes them a key demographic ...
Jul 1, 2026
0
4
COVID-19 vaccine boosters not only protect against SARS-CoV-2—the virus behind the most recent pandemic—but may also help protect against some future coronaviruses that risk spreading from animals to humans, Cambridge researchers ...
Jul 1, 2026
0
12
Known by acronyms that need no explanation, viruses like COVID, SARS and Ebola conjure images of medics in protective suits and spark fear in populations worldwide.
Jun 25, 2026
0
11
Most pandemics start when a pathogen spreads from animals to humans. It's a leading explanation for the COVID-19 pandemic: The SARS-CoV-2 virus, which causes COVID-19, is a cousin of coronaviruses that live in bats.
Jun 21, 2026
1
19
Researchers from Trinity have discovered how two deadly coronaviruses (SARS1 and MERS) outsmart one of our most important antiviral defenses by shutting down parts of the immune system. The findings help explain why certain ...
Jun 18, 2026
0
7
Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine's key component was designed entirely by AI and has now been ...
Jun 9, 2026
0
5
Our genomes contain hundreds of genes with antiviral jobs that are called into action when a virus succeeds in infecting one of our cells. By acting cooperatively, these genes provide defense against a wide range of viruses, ...
Jun 8, 2026
0
4
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
Jun 7, 2026
0
138
A vaccine targeting a broad range of viruses that was designed using artificial intelligence had a "modest" effect on immune systems in a small, early trial, according to a new study.
Jun 6, 2026
0
57
